Bienvenue dans – Welkom bij:
Bienvenidos en – Welcome to:
SFB-Pharma
If you want to reach me please send a message to:
Christine Laroche [email protected]
DRUGS.COM – NEW APPROVALS BELOW
- FDA Approves Eydenzelt (aflibercept-boav), a Biosimilar to Eylea
- Libtayo (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
- FDA Approves Lasix ONYU ( for Treatment of Edema in Heart Failure
- U.S. FDA Approves Simponi (golimumab) for the Treatment of Pediatric Ulcerative Colitis
- FDA Approves Jascayd (nerandomilast) to Treat Idiopathic Pulmonary Fibrosis